Online inquiry

IVTScrip™ mRNA-Human AFG3L2, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A))   (CAT#: GTTS-WK8985MR)

This product GTTS-WK8985MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 0 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the AFG3L2 protein. This product can be used in Natural killer T (NKT) cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 0
Species Human
RefSeq NM_006796.3
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 10939
UniProt ID Q9Y4W6
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human AFG3L2, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) (GTTS-WK8985MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK19414MR IVTScrip™ mRNA-Human ANKRD28, (Cap 1, 5-Methyl-CTP, 120 nt-poly(A)) mRNA ANKRD28
GTTS-WK10880MR IVTScrip™ mRNA-Human ABLIM3, (Cap 1, Pseudo-UTP, 120 nt-poly(A)) mRNA ABLIM3
GTTS-WK12231MR IVTScrip™ mRNA-Human ADGB, (Cap 1, 5-Methyl-CTP, 120 nt-poly(A)) mRNA ADGB
GTTS-WK6294MR IVTScrip™ mRNA-Human TM4SF1, (Cap 1, 5-Methoxy-UTP, 30 nt-poly(A)) mRNA TM4SF1
GTTS-WK19701MR IVTScrip™ mRNA-Human ANKRD13D, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ANKRD13D
GTTS-WK22672MR IVTScrip™ mRNA-Human ARPC5L, (Cap 0, 2-Thio-UTP, 120 nt-poly(A)) mRNA ARPC5L
GTTS-WK25621MR IVTScrip™ mRNA-Human ARHGEF6, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ARHGEF6
GTTS-WK13405MR IVTScrip™ mRNA-Human ADAMTS6, (Cap 1, 5-Methoxy-UTP, 30 nt-poly(A)) mRNA ADAMTS6
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
×

Webinar Register

Simone Pinto Carneiro, Ph.D.

Group Leader, Ludwig-Maximilians-University of Munich

date-time 10 AM EDT | May 19, 2026

Register Now →